000650 Stock Overview
Renhe Pharmacy Co., Ltd. produces and sells pharmaceutical products.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Renhe Pharmacy Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.90 |
| 52 Week High | CN¥7.59 |
| 52 Week Low | CN¥5.09 |
| Beta | 0.40 |
| 11 Month Change | -12.33% |
| 3 Month Change | -10.20% |
| 1 Year Change | -3.91% |
| 33 Year Change | -46.07% |
| 5 Year Change | -19.95% |
| Change since IPO | -20.59% |
Recent News & Updates
Recent updates
Shareholder Returns
| 000650 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0.3% | -3.7% | -2.2% |
| 1Y | -3.9% | -17.3% | -17.9% |
Return vs Industry: 000650 exceeded the CN Pharmaceuticals industry which returned -17.3% over the past year.
Return vs Market: 000650 exceeded the CN Market which returned -17.9% over the past year.
Price Volatility
| 000650 volatility | |
|---|---|
| 000650 Average Weekly Movement | 4.3% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.0% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 000650's share price has been volatile over the past 3 months.
Volatility Over Time: 000650's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 5,792 | n/a | www.renheyaoye.com |
Renhe Pharmacy Co., Ltd. produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is headquartered in Nanchang, China.
Renhe Pharmacy Co.,Ltd Fundamentals Summary
| 000650 fundamental statistics | |
|---|---|
| Market cap | CN¥8.17b |
| Earnings (TTM) | CN¥562.25m |
| Revenue (TTM) | CN¥4.91b |
14.5x
P/E Ratio1.7x
P/S RatioIs 000650 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000650 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.91b |
| Cost of Revenue | CN¥3.15b |
| Gross Profit | CN¥1.76b |
| Other Expenses | CN¥1.20b |
| Earnings | CN¥562.25m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 28, 2024
| Earnings per share (EPS) | 0.41 |
| Gross Margin | 35.90% |
| Net Profit Margin | 11.44% |
| Debt/Equity Ratio | 0% |
How did 000650 perform over the long term?
See historical performance and comparison